| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |